Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymorphone IR in Post-Surgical Abdominal Pain
NCT00226395Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxymorphone in acute pain (4 arms), sponsored by Endo International plc. Primary endpoint: Time to discontinuation due to all causes. Started Sep 2004; status: completed.
02
Drugs
oxymorphone
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT00226395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226395.